 |
|
 |
| |
 |
|
Class Information
Number: 435/344.1
Name: Chemistry: molecular biology and microbiology > Animal cell, per se (e.g., cell lines, etc.); composition thereof; process of propagating, maintaining or preserving an animal cell or composition thereof; process of isolating or separating an animal cell or composition thereof; process of preparing a composition containing an animal cell; culture media therefore > Animal cell, per se, expressing immunoglobulin, antibody, or fragment thereof > Immunoglobulin or antibody binds a microorganism or normal or mutant component or product thereof (e.g., animal cell, cell surface antigen, secretory product, etc.) > Binds a cancer cell or component or product thereof (e.g., cell surface antigen, etc.) > Binds an antigen characterized by name or molecular weight (e.g., cea, nca, cc glycoprotein, melanoma gp 150 antigen, etc.)
Description: Subject matter involving an animal cell which produces a monoclonal antibody or antigen-binding fragment thereof whose antigen-binding site(s) will combine with an antigen that is an integral or isolated part of cancer cell, or that is shed or secreted by a cancer cell, and that is disclosed by name or molecular weight.
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7541044 |
Administration of 5T4 antigen and immune response of cells expressing 5T4 and CEA antigens |
Jun. 2, 2009 |
| 7521209 |
Insertion of furin protease cleavage sites in membrane proteins and uses thereof |
Apr. 21, 2009 |
| 7470521 |
RAGE protein derivatives |
Dec. 30, 2008 |
| 7446179 |
CD19-specific chimeric T cell receptor |
Nov. 4, 2008 |
| 7446191 |
DNA construct encoding CE7-specific chimeric T cell receptor |
Nov. 4, 2008 |
| 7381560 |
Expression and use of anti-CD20 antibodies |
Jun. 3, 2008 |
| 7374936 |
Method and means for site directed therapy |
May. 20, 2008 |
| 7354762 |
Method for producing CE7-specific redirected immune cells |
Apr. 8, 2008 |
| 7265209 |
CE7-specific chimeric T cell receptor |
Sep. 4, 2007 |
| 7122184 |
Specific monoclonal antibody against terbinafine |
Oct. 17, 2006 |
| 7101979 |
Antibodies to antiangiogenic compositions and methods |
Sep. 5, 2006 |
| 7087727 |
Periostin-based diagnostic assays |
Aug. 8, 2006 |
| 7070995 |
CE7-specific redirected immune cells |
Jul. 4, 2006 |
| 7064188 |
Monoclonal antibodies which identify the glycoprotein carrying the CA125 epitope |
Jun. 20, 2006 |
| 7041499 |
Immuno activation of CS1 receptor in natural killer cells to inhibit tumor cell growth |
May. 9, 2006 |
| 6955924 |
Laminin chains: diagnostic uses |
Oct. 18, 2005 |
| 6911178 |
Rh blood group antigen compositions and methods of use |
Jun. 28, 2005 |
| 6890724 |
Methods and compositions for neural progenitor cells |
May. 10, 2005 |
| 6884417 |
Monoclonal antibodies immunoreactive with lipopolysaccharide binding protein (LBP) and methods of their use |
Apr. 26, 2005 |
| 6861511 |
Detection and quantification of neu related proteins in the biological fluids of humans |
Mar. 1, 2005 |
| 6720156 |
Superficial zone protein-binding molecules and uses thereof |
Apr. 13, 2004 |
| 6699475 |
Recombinant pox virus for immunization against tumor-associated antigens |
Mar. 2, 2004 |
| 6689607 |
Human tumor, necrosis factor receptor-like proteins TR11, TR11SV1 and TR11SV2 |
Feb. 10, 2004 |
| 6660488 |
Antibodies for the alpha platelet-derived growth factor receptor |
Dec. 9, 2003 |
| 6653129 |
Method for isolation of cells from a solution |
Nov. 25, 2003 |
| 6485970 |
Immunointeractive antibody |
Nov. 26, 2002 |
| 6482614 |
Stress proteins and uses therefor |
Nov. 19, 2002 |
| 6465173 |
Anti-idiotypic antibody and its use in diagnosis and therapy in HIV-related disease |
Oct. 15, 2002 |
| 6451981 |
Antibodies against lymphocyte-associated cell surface protein LAM-1 |
Sep. 17, 2002 |
| 6447776 |
Mutations of E cadherin as a basis for the diagnosis and therapy of human malignant tumors |
Sep. 10, 2002 |
| 6441142 |
Immunoassay for peanut allergen |
Aug. 27, 2002 |
| 6387698 |
MAGE-10 encoding CDNA, the tumor rejection antigen precursor MAGE-10, antibodies specific to the molecule, and uses thereof |
May. 14, 2002 |
| RE37596 |
Monoclonal antibodies against tumor-associated antigens, a process for the preparation thereof and the use thereof |
Mar. 19, 2002 |
| 6355444 |
Carcinoma associated antigen (SK1) monoclonal antibodies against SK1, methods of producing these antibodies and uses therefor |
Mar. 12, 2002 |
| 6316600 |
Methods for the production of chicken monoclonial antibodies |
Nov. 13, 2001 |
| 6294172 |
Monoclonal antibodies with specificity for membrane-associated antigens |
Sep. 25, 2001 |
| 6277599 |
Anti-CEA antibody designated 806.077, hybridoma and method of manufacture |
Aug. 21, 2001 |
| 6258939 |
PSCA antibodies and hybridomas producing them |
Jul. 10, 2001 |
| 6245898 |
Monoclonal antibodies that recognize antigens associated with tumor metastasis |
Jun. 12, 2001 |
| 6232448 |
Immunological materials and methods for detecting dihydropyrimidine dehydrogenase |
May. 15, 2001 |
| 6221580 |
Anti-idiotypic and its uses in diagnosis and therapy in HIV-related disease |
Apr. 24, 2001 |
| 6197297 |
Monoclonal antibody specific to polypeptide which induces interferon-gamma production |
Mar. 6, 2001 |
| 6143505 |
Laminin chains: diagnostic and therapeutic use |
Nov. 7, 2000 |
| 6143559 |
Methods for the production of chicken monoclonal antibodies |
Nov. 7, 2000 |
| 6143296 |
Antibody 67D2 |
Nov. 7, 2000 |
| 6051229 |
Human-human hybridom for neoplasms CLNH5 and CLNH11 specific antibody compositions |
Apr. 18, 2000 |
| 6051693 |
CLNH11-specific antibodies |
Apr. 18, 2000 |
| 6004553 |
TRAF inhibitors |
Dec. 21, 1999 |
| 5972628 |
Pyruvatekinase-iosenzyme typ-M2 (Tumor-M2-PK)-specific antibody/process for the preparation and use thereof |
Oct. 26, 1999 |
| 5916561 |
Monoclonal antibody against CD44v6 |
Jun. 29, 1999 |
|
|
|
 |
|
 |
|
| |
Randomly Featured Patents |
|
